The Influence of Postoperative Postures on Persistent Sub-foveal Fluid After Scleral Buckle Surgery
NCT ID: NCT02294708
Last Updated: 2014-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2014-01-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
supine
postoperative postures: patients in this arm are assigned to adopt supine position for 24 hours after the surgery
postoperative postures
two postoperative postures: supine and temporal-lateral
temporal lateral
postoperative postures: patients in this arm are assigned to adopt temporal lateral position for 24 hours after the surgery
postoperative postures
two postoperative postures: supine and temporal-lateral
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
postoperative postures
two postoperative postures: supine and temporal-lateral
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* macula off
* treated by successful scleral buckle surgery
* recent onset with symptom within 1 month
Exclusion Criteria
* intraoperative or postoperative injection of long-acting gas
* with other eye diseases than RRD
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhi-zhong Ma
chair of ophthalmology department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hui-Jin Chen, M.D.
Role: STUDY_DIRECTOR
Peking University Third Hospital
Chang-Guan Wang, M.D.
Role: STUDY_CHAIR
Peking University Third Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Third Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hui-Jin Chen, M.D.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PekingUTH-RD-2014
Identifier Type: -
Identifier Source: org_study_id